Why the study?
What are the pharmacokinetic profiles (plasma levels) and pharmacodynamic effects (heart rate and blood pressure) of acute oral metoprolol in geriatric patients with moderate hypertension?
What are the pharmacokinetic profiles (plasma levels) and pharmacodynamic effects (heart rate and blood pressure) of acute oral metoprolol in geriatric patients with moderate hypertension?
Acute oral administration of metoprolol in geriatric patients demonstrates high inter-individual variability in peak plasma concentrations compared to younger populations, despite a similar plasma half-life.
May require individualized dosing in geriatric hypertension; extends PK data to older adults but leaves optimal titration strategies open.
Metoprolol, a cardioselective beta-blocking agent, has been given orally to 12 geriatric patients with moderate hypertension. Drug levels of metoprolol as well as the effect of the drug on resting heart rate and BP were studied. Metoprolol was given in a dose of 20 mg, and 8 of the 12 patients also received a 50 mg dose. After the 20 mg dose the peak drug plasma concentration varied between 5 and 80 ng/ml (mean 33), and after the 50 mg dose between 14 and 212 ng/ml (mean 111). This variation is much greater than that seen in earlier studies on healthy volunteers and on a group of non-geriatric hypertensive patients. Plasma half-life of metoprolol averaged about 3.5 hours after both the 20 mg and the 50 mg dose; this does not differe from the plasma half-life in earlier studies in younger age groups. The variability observed in the study might be explained multifactorially, e.g. by different body weight, absorption and/or first-pass effect of the drug.
No takes yet. Share an insight, caveat, or question.
Lundborg et al. (1976) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: